MIMEDX EPIFIX® Receives Reimbursement Approval in Japan
MiMedx Group, Inc (MDXG)
Last mimedx group, inc earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=213465&p=irol-irhome
Company Research
Source: GlobeNewswire
Provides Favorable Access to a New $500 Million Market for the Treatment of Refractory Diabetic and Venous Ulcers for EPIFIX – the First and Only Amniotic Tissue Product Approved for Use in Japan MARIETTA, Ga., Sept. 12, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that the Japanese Ministry of Health, Labour and Welfare (JMHLW) approved reimbursement of EPIFIX® to treat refractory or hard-to-heal lower extremity diabetic and venous ulcers. The Company is in the last stages of preparing for full product launch, anticipated in the fourth quarter. The Company estimates the Japanese total addressable market associated with the scope of the JMHLW reimbursement decision to be approximately $500 million based on a recently completed third party market study. The study estimated that there are more than 400,000 hard-to-heal wounds that present each year in Japan that can be treated b
Show less
Read more
Impact Snapshot
Event Time:
MDXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXG alerts
High impacting MiMedx Group, Inc news events
Weekly update
A roundup of the hottest topics
MDXG
News
- MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30GlobeNewswire
- Global Advanced Wound Dressing Market is on track to reach a valuation of US$ 8,374.50 Million by 2034 at a CAGR of 2.80% | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Spectral AI, Inc. (NASDAQ:MDAI) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- MiMedx slips as FDA reaffirms position on Axiofill [Seeking Alpha]Seeking Alpha
- MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA [Yahoo! Finance]Yahoo! Finance
MDXG
Earnings
- 2/28/24 - Beat
MDXG
Sec Filings
- 4/10/24 - Form 4
- 3/27/24 - Form 8-K
- 3/18/24 - Form 3
- MDXG's page on the SEC website